Vivet Therapeutics’ CEO, Jean-Philippe Combal, will be attending FierceBiotech 3rd Drug Development Forum in Boston (October 1-3 2018). He will be a speaker during the session “Select Ideal Animal Models for Early Research to Improve the Preclinical-to-Clinical Transition” (October 2 at 3.30pm / TRACK — Breakthroughs in Guiding Early-Stage Research) and he will moderate the following discussion: “Critically Examine the M&A Mindset in Biotech and Pharma” (October 3 at 3.50pm / TRACK — Strategic Deal-Making & Partnering).